FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/10/028601 [Registered on: 23/10/2020] Trial Registered Prospectively
Last Modified On: 22/10/2020
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   adherence and treatment satisfaction in Hypertensive patients 
Scientific Title of Study   A cross-sectional study to evaluate the adherence and treatment satisfaction of Angiotensin Receptor Blockers vs Non Angiotensin Receptor Blockers among Hypertensive Patients 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Arshiya 
Designation  Junior Resident 
Affiliation  Government Medical College, Patiala 
Address  Department of Pharmacology, Government Medical College, Patiala
Government Medical College, Patiala
Patiala
PUNJAB
147001
India 
Phone  09646732003  
Fax    
Email  arshiyasehgal26@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vijay Kumar Sehgal 
Designation  Professor & HOD 
Affiliation  Government Medical College, Patiala 
Address  Department of Pharmacology, Government Medical College, Patiala
Room No 1 ,Department of PharmacologyGovernment Medical College, Patiala
Patiala
PUNJAB
147001
India 
Phone  09646732001  
Fax    
Email  vijayksehgal@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Arshiya 
Designation  Junior Resident 
Affiliation  Government Medical College, Patiala 
Address  Department of Pharmacology, Government Medical College, Patiala
Government Medical College, Patiala

PUNJAB
147001
India 
Phone  09646732003  
Fax    
Email  arshiyasehgal26@gmail.com  
 
Source of Monetary or Material Support  
Room No 1 Department of Pharmacology, Government Medical College, Patiala, Punjab, India 
 
Primary Sponsor  
Name  department of pharmacology 
Address  Government Medical College, Patiala 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NA  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Arshiya   Government Medical College& Rajindra Hospital  Room No 14, Department of Medicine,Rajindra Hospital
Patiala
PUNJAB 
09646732003

arshiyasehgal26@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research &Ethics Committee,Government Medical College, Patiala  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NA  NA 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1 Adults age > 18 years
2 Patients on monotherapy and combination of antihypertensive drugs (ARBs and other drugs)
3 Patients with HTN diagnosed and taking antihypertensive medication at least 4 months prior to start of the study
 
 
ExclusionCriteria 
Details  1 Children
2 Pregnant women
3 Seriously ill and acutely ill patients
4 Patients who are not willing to give written informed consent
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To evaluate and compare the Medication Adherence among Hypertensive patients taking Angiotensin Receptor Blockers based regimen and other regimens.
2.To evaluate and compare the treatment satisfaction among Hypertensive patients taking Angiotensin Receptor Blockers based regimen and other regimens.
 
At 3mths
 
 
Secondary Outcome  
Outcome  TimePoints 
1.To evaluate the efficacy of the ARBs among Hypertensive patients taking ARB based regimen and other regimens by assessing the number of patients who achieved target BP
2.To evaluate the correlation between the BP, medication adherence score and treatment satisfaction score among patients taking ARBs and other regimens.
 
At 3mths 
 
Target Sample Size   Total Sample Size="164"
Sample Size from India="164" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/10/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NA 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION - Hypertension is the most common cardiovascular disease.Worldwide   Prevalence of hypertension exceeds 1.3 billion. The number of  adults  with  hypertension  in  2025  was  predicted  to  increase  by  60%  ,a  total  of  1.56  billion.

 AIMS & OBJECTIVES - To evaluate and compare the Medication  Adherence  among Hypertensive patients taking Angiotensin Receptor Blockers  based regimen and other regimens. To evaluate  and compare the  treatment satisfaction  among Hypertensive  patients taking  Angiotensin Receptor Blockers  based regimen and other regimens.

MATERIALS &METHODS - This observational cross sectional study will be conducted  over 164 patients,82  in each group to evaluate the  adherence and treatment satisfaction of antihypertensive medications in hypertensive patients. We will enroll hypertensive patients coming to department of medicine, Rajindra Hospital attached to Govt. Medical College Patiala. The patients fulfilling the inclusion criteria and the exclusion criteria will be included in the study after taking the written informed consent. Patients will be divided into two groups i.e. Group 1 involving hypertensive patients taking ARBs in monotherapy or in combination therapy and Group 2, involving hypertensive patients taking antihypertensive medications  other than ARBs, in monotherapy  or in combination therapy Adherence will be assessed byMorisky Green and Levine Adherence Scale. Patient treatment satisfaction will be evaluated using Treatment Satisfaction Questionnaire for Medication (TSQM). We will also look for the number of patients who have achieved BP control i.e. who have successfully attained the BP equal to or less than the target BP.

RESULTS- Adherence and treatment satisfaction scores will be calculated and compared among Group 1 and Group 2 hypertensive patients.  Lastly, a correlation analysis will be done between the BP and the adherence and treatment satisfaction scores.

 

 
Close